Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models

New therapies are required for patients with non-small cell lung cancer (NSCLC) for which the current standards of care poorly affect the patient prognosis of this aggressive cancer subtype. In this preclinical study, we aim to investigate the efficacy of Fingolimod, a described inhibitor of sphingo...

Full description

Bibliographic Details
Main Authors: Tristan Rupp, Solène Debasly, Laurie Genest, Guillaume Froget, Vincent Castagné
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:International Journal of Molecular Sciences
Subjects:
non-small cell lung cancer
preclinical models
tumor progression
Fingolimod
dimethyl fumarate
Online Access:https://www.mdpi.com/1422-0067/23/15/8192

Internet

https://www.mdpi.com/1422-0067/23/15/8192

Similar Items